Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation program.

Kramer F, Riedemann M, Abera TA, Hem J, Herce A, Marneth AE, Rolles B, Englert M, Hackenbroch C, Faiz M, Papanastasiou M, Reiter AH, Carr SA, Li R, Qiu X, Hobbs GS, Fouda R, Pozdnyakova O, Miyauchi M, Nam AS, Mullally A

Open source

DOI: 10.1172/jci201732
Published: 2026 Oct 29
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci201732,
  title = {Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation program.},
  author = {Kramer F and Riedemann M and Abera TA and Hem J and Herce A and Marneth AE and Rolles B and Englert M and Hackenbroch C and Faiz M and Papanastasiou M and Reiter AH and Carr SA and Li R and Qiu X and Hobbs GS and Fouda R and Pozdnyakova O and Miyauchi M and Nam AS and Mullally A},
  year = {2026},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci201732},
  url = {https://doi.org/10.1172/jci201732}
}

RIS

TY  - JOUR
TI  - Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation program.
AU  - Kramer F
AU  - Riedemann M
AU  - Abera TA
AU  - Hem J
AU  - Herce A
AU  - Marneth AE
AU  - Rolles B
AU  - Englert M
AU  - Hackenbroch C
AU  - Faiz M
AU  - Papanastasiou M
AU  - Reiter AH
AU  - Carr SA
AU  - Li R
AU  - Qiu X
AU  - Hobbs GS
AU  - Fouda R
AU  - Pozdnyakova O
AU  - Miyauchi M
AU  - Nam AS
AU  - Mullally A
PY  - 2026
JO  - The Journal of clinical investigation
DO  - 10.1172/jci201732
UR  - https://doi.org/10.1172/jci201732
ER  -

APA

F, K., M, R., TA, A., J, H., A, H., AE, M., B, R., M, E., C, H., M, F., M, P., AH, R., SA, C., R, L., X, Q., GS, H., R, F., O, P., M, M., AS, N., & A, M. (2026). Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation program.. The Journal of clinical investigation. https://doi.org/10.1172/jci201732

Source records

pubmed · retrieved 2026-11-10T06:56:15.102Z
europe-pmc · retrieved 2026-11-10T06:56:15.115Z